Udvalget for Humanmedicinske Lægemidler (CHMP) vurderede, at Orgaluran havde vist sig at være effektivt, og at tendensen hen imod lavere resultater sammenlignet med GnRH- agonister var tilfredsstillende.
The Committee for Medicinal products for Human Use (CHMP) considered that Orgaluran had shown its effectiveness, and that the tendency towards lower results compared with the GnRH agonists was acceptable.